StockData
HCW Biologics Inc. logo

HCW Biologics Inc. (HCWB) stock

HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)

Close on Nov 18, 2026Market cap $1.40MP/E –Yield –

Earnings

HCW Biologics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 13, 2026
Q3 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$135.57K
+1969.7% on a year earlier
EPS, Q2 FY2026
-$11.58
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of HCW Biologics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 13, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 14, 2026during market hours$135.57K+1969.7%-$11.58Release
Q1 FY2026ended Mar 31, 2026May 14, 2026after the close$6.50M+128231.7%–Release
Q4 FY2025ended Dec 31, 2025Mar 31, 2026after the close$27.01K-93.2%–Release
Q3 FY2025ended Sep 30, 2025Nov 14, 2025after the close$15.61K-96.3%–Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025after the close$6.55K-98.9%–Release
Q1 FY2025ended Mar 31, 2025May 15, 2025after the close$5.07K-99.5%-$0.05Release
Q4 FY2024ended Dec 31, 2024Mar 28, 2025during market hours$394.80K-69.6%–Release
Q3 FY2024ended Sep 30, 2024Nov 14, 2024after the close$426.42K-50.0%–Release
Q2 FY2024ended Jun 30, 2024Aug 14, 2024after the close$618.85K-0.6%–Release
Q1 FY2024ended Mar 31, 2024May 15, 2024after the close$1.10M+2526.4%-$0.20Release
Q4 FY2023ended Dec 31, 2023Apr 1, 2024after the close$1.30M0.0%-$0.30Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

HCW Biologics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When HCW Biologics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases HCW Biologics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Update
  4. Update
  5. Results
  6. Update
  7. Update
  8. Update
  9. Update
  10. Results
  11. News
  12. Results
  13. Update
  14. Update
  15. Update

See a number that looks wrong?